Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
D4774-24 – Standard Test Method Technical Guide
🎯 Objective and Scope of D4774-24
The ASTM D4774-24 standard specifically addresses the critical need to reduce medication errors in anesthesiology by standardizing the user-applied labels on unlabeled syringes. This specification covers the size, color, pattern, and typography used by clinicians or their agents to clearly identify drug contents immediately before use.
It is crucial to note that this specification does not cover labels pre-applied by drug manufacturers. The standard operates within the framework of internationally recognized principles for standardization and emphasizes that color coding serves solely as an aid; it does not replace the mandatory practice of reading the label before drug administration.
📏 Label Specifications and Color Design
The standard provides strict dimensional requirements to ensure consistency across clinical environments. User-applied labels must have a nominal length of 25 mm to 35 mm and a width of 10 mm to 13 mm. The background color must be selected so it does not interfere with the user’s ability to write critical information on the label. All colors are defined by the Pantone Matching System (PMS).
| 🟦 Feature | 📐 Specification |
|---|---|
| Label Length | 25 mm to 35 mm |
| Label Width | 10 mm to 13 mm |
| Color Reference System | Pantone Matching System (PMS) |
| Antagonist Stripe Width | 1 mm |
| Antagonist Stripe Angle | 45° (lower left to upper right) |
🎨 Antagonist Labeling and Best Practices
A unique feature of D4774-24 is the specification for antagonist labels. To visually distinguish drugs that reverse the effects of agonists, the label must feature 1-mm wide diagonal stripes of the corresponding agonist color alternating with 1-mm wide white stripes. These stripes must run from the lower left to the upper right at a 45° angle relative to the long axis of the label. The drug name must appear in the center of the label, and the striping is omitted directly behind and below the name to ensure maximum readability.
⚠️ Critical Safety Note: The use of color is strictly intended as a visual aid for drug class identification. It does not absolve the user from the duty to read the label carefully to identify the correct drug before administration. Color should never be the sole means of identification.
💡 Practical Alternative: The standard permits the use of white labels with black printing as an alternative to the full color scheme. This provides flexibility for institutions seeking to simplify their labeling inventory or address color vision deficiency considerations among staff.
❓ Frequently Asked Questions
🔍 What is the primary goal of the D4774-24 standard?
The primary objective is to reduce the inherent risk of medication errors in anesthesiology by providing a consistent, standardized labeling system for syringes filled by the user. This facilitates the correct identification of drug content immediately before use.
⚡ What are the exact specifications for antagonist drug labels?
Antagonist labels require 1-mm wide diagonal stripes of the agonist color alternating with 1-mm wide white stripes. The stripes must run from the lower left to the upper right at a 45° angle relative to the long axis of the label.
📌 What are the permitted label dimensions under this standard?
The standard specifies that user-applied drug labels shall have a nominal length of 25 mm to 35 mm and a width of 10 mm to 13 mm.
💡 Are there alternative labeling options allowed by the standard?
Yes. The user may alternatively use white labels with black printing rather than the fully colored labels to meet specific operational needs or address color vision accessibility requirements.